Phibro Animal Health Corp. (PAHC) Social Stream



Phibro Animal Health Corp. (PAHC): $12.29

-0.13 (-1.05%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

PHIBRO ANIMAL HEALTH CORP (PAHC) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering PAHC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-03 2 $23 $17 $20 $12.5 60%
2021-11-18 3 $23 $17 $21 $12.5 68%
2022-02-11 3 $23 $17 $21 $12.5 68%
2022-05-06 3 $23 $18 $21.333 $12.5 70.66%
2022-08-13 3 $23 $18 $21 $12.5 68%
2022-09-10 3 $22 $16 $19.666 $12.5 57.33%
2022-09-17 3 $21 $16 $18 $12.5 44%
2022-10-26 3 $21 $14 $17.333 $12.5 38.66%
2022-11-09 3 $20 $14 $17 $12.5 36%
2022-11-17 3 $20 $12 $16.333 $12.5 30.66%

The Trend in the Analyst Price Target


Over the past 16 months, PAHC's average price target has gone down $5.67.

Over the past 44 weeks, PAHC's average upside potential has been 15.29%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-01-10 3 23 17 21.000 21.27 -1.27%
2022-02-11 3 23 17 21.000 21.02 -0.1%
2022-09-10 3 22 16 19.666 15.09 30.32%
2022-11-09 3 20 14 17.000 14.42 17.89%
2022-11-17 3 20 12 16.333 12.60 29.63%

PAHC Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
4 0 0 1 1 1 3

The Trend in the Broker Recommendations


Over the past 43 weeks, PAHC's average broker recommendation rating worsened by 0.67.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, PHIBRO ANIMAL HEALTH CORP's number of analysts covering the stock is greater than 78.87% of them.
  • In terms of how PHIBRO ANIMAL HEALTH CORP fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -85.75% of that group.
  • In terms of how PHIBRO ANIMAL HEALTH CORP fares relative to stocks in the mid market cap category, note that its average analyst price target is higher than 216.37% of that group.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, PHIBRO ANIMAL HEALTH CORP's upside potential (average analyst target price relative to current price) is higher than 223.85% of them.

Stocks similar to PHIBRO ANIMAL HEALTH CORP in the Pharmaceutical Products industry regarding analyst recommendations and price targets are SAGE, FGEN, and TARO.

Make investment decisions regarding PAHC using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7535 seconds.